EconPapers    
Economics at your fingertips  
 

Epiregulon: Single-cell transcription factor activity inference to predict drug response and drivers of cell states

Tomasz Włodarczyk, Aaron Lun, Diana Wu, Minyi Shi, Xiaofen Ye, Shreya Menon, Shushan Toneyan, Kerstin Seidel, Liang Wang, Jenille Tan, Shang-Yang Chen, Timothy Keyes, Aleksander Chlebowski, Adrian Waddell, Wei Zhou, Yangmeng Wang, Qiuyue Yuan, Yu Guo, Liang-Fu Chen, Bence Daniel, Antonina Hafner, Meng He, Alejandro Chibly, Yuxin Liang, Zhana Duren, Ciara Metcalfe, Marc Hafner, Christian W. Siebel, M. Ryan Corces, Robert Yauch (), Shiqi Xie () and Xiaosai Yao ()
Additional contact information
Tomasz Włodarczyk: Genentech Inc
Aaron Lun: Genentech Inc
Diana Wu: Genentech Inc
Minyi Shi: Genentech Inc
Xiaofen Ye: Genentech Inc
Shreya Menon: Gladstone Institutes
Shushan Toneyan: Genentech Inc
Kerstin Seidel: Genentech Inc
Liang Wang: Genentech Inc
Jenille Tan: Genentech Inc
Shang-Yang Chen: Genentech Inc
Timothy Keyes: Genentech Inc
Aleksander Chlebowski: Genentech Inc
Adrian Waddell: Genentech Inc
Wei Zhou: Genentech Inc
Yangmeng Wang: Genentech Inc
Qiuyue Yuan: Clemson University
Yu Guo: Genentech Inc
Liang-Fu Chen: Genentech Inc
Bence Daniel: Genentech Inc
Antonina Hafner: Genentech Inc
Meng He: Genentech Inc
Alejandro Chibly: Genentech Inc
Yuxin Liang: Genentech Inc
Zhana Duren: Clemson University
Ciara Metcalfe: Genentech Inc
Marc Hafner: Genentech Inc
Christian W. Siebel: Genentech Inc
M. Ryan Corces: Gladstone Institutes
Robert Yauch: Genentech Inc
Shiqi Xie: Genentech Inc
Xiaosai Yao: Genentech Inc

Nature Communications, 2025, vol. 16, issue 1, 1-19

Abstract: Abstract Transcription factors (TFs) and transcriptional coregulators are emerging therapeutic targets. Gene regulatory networks (GRNs) can evaluate pharmacological agents and identify drivers of disease, but methods that rely solely on gene expression often neglect post-transcriptional modulation of TFs. We present Epiregulon, a method that constructs GRNs from single-cell ATAC-seq and RNA-seq data for accurate prediction of TF activity. This is achieved by considering the co-occurrence of TF expression and chromatin accessibility at TF binding sites in each cell. ChIP-seq data allows motif-agonistic activity inference of transcriptional coregulators or TF harboring neomorphic mutations. Epiregulon accurately predicted the effects of AR inhibition across different drug modalities including an AR antagonist and an AR degrader, delineated the mechanisms of a SMARCA4 degrader by identifying context-dependent interaction partners, and prioritized drivers of lineage reprogramming and tumorigenesis. By mapping gene regulation across various cellular contexts, Epiregulon can accelerate the discovery of therapeutics targeting transcriptional regulators.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-62252-5 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62252-5

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-62252-5

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-08-04
Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62252-5